37 /100
MEDIUM RISK
Score updated Apr 13, 2026

ALXO

ALX Oncology Holdings Inc. — Stock Dilution Tracker

Track ALXO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track ALXO — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
30
💰 Cash Runway
65
📊 Float Risk
14
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
24%
💰 Capital Raise 33%
• Under 12 months cash (11mo)
• Active ATM program with $118M remaining capacity
🔄 Reverse Split 25%
• 52-week low $0.40 has breached $1
• 11 months cash with weak price
🔔 Track ALXO — Get forecast alerts →
💹 Market Data
Market Cap$223.73M
Shares Outstanding131.61M
Float104.06M
Cash$44.79M
Debt$14.77M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.9% shares (2025Q4 vs prior)
56 institutional holders · 30.01M shares
#1 venBio Partners LLC 9.70M shares
#2 MILLENNIUM MANAGEMENT LLC 3.30M shares
#3 Redmile Group, LLC 3.26M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.22M
Days to Cover2.9
% of Float2.1%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2020
xbrl XBRL CONVERTIBLE Dec 31, 2020
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 05, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track ALXO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALXO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required